Skip to main content

Table 5 Clonogenic survivals were fitted to the linear quadratic model and SER was calculated

From: DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway

 

α value (Gy−1)

β value (Gy−2)

α/β value (Gy)

SF2

SER (ratio of SF2)

Kyse150-vector

− 0.03

0.12

− 0.25

0.66

1.52

Kyse150-DAB2IP

0.08

0.17

0.47

0.43

 

EC109-shLuc

0.09

0.09

0.95

0.59

0.87

EC109-shDAB2IP

0.05

0.07

0.68

0.67

 
  1. SF2: survival fraction at 2 Gy; SER: sensitizing enhancement ratio
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us